An astonishing breakthrough in neuroscience is poised to accelerate the study and treatment of neurological disorders. Scientists have successfully grown miniaturized human brains, called brain organoids, in the laboratory which can connect to and control the contraction of muscle tissue. This unprecedented development provides an advanced model to elucidate how the brain develops and goes awry in conditions like epilepsy, autism, and dementia. Moreover, the research underscores the vast promise of stem cell therapy to potentially restore lost functioning in patients with neurological disease.
Stem Cell Medical Center, a pioneering regenerative medicine clinic in Antigua, specializes in deploying the latest stem cell advances to treat neurological conditions. By harnessing the power of nature’s healing toolkit, their brain disorder therapies seek to reverse damage, regain lost function, and help patients reclaim their lives.
Brain organoids are clusters of brain cells meticulously cultured from stem cells in the laboratory to resemble the developing human brain. Through precise control of their growth environment, scientists coax the stem cells to specialize into neurons and self-organize into various brain regions and interconnections.
This 3D “mini-brain” technology has become an invaluable tool for modeling brain development and disease. Derived from a patient’s own cells, brain organoids preserve that individual’s unique genetic background. Scientists have already leveraged them to gain insights into autism, schizophrenia, Zika virus, and brain cancer.
Yet a roadblock has constrained the potential of brain organoids. As the mini-brains grow larger, their inner regions become starved of nutrients and oxygen, eventually leading to cell death. This has restricted organoids from maturing past an embryonic stage and forming more intricate connections.
The latest breakthrough circumvents this through a clever organoid “patch” method to enable unprecedented development and connectivity.
An international team led by Dr. Alysson Muotri at the University of California, San Diego adopted an innovative approach to push brain organoids further than ever before. They grew the organoids to a certain size, then sliced them into thin slivers optimally sized to receive nutrients throughout the tissue. These organoid “patches” could survive, mature, and form intricate neural networks when nourished in gel-based laboratory dishes.
Remarkably, when implanted next to a mouse’s spinal cord and surrounding muscle tissue, the human organoid patches sent out neuron projections. These made functional connections with the spinal cord that allowed the organoid patches to trigger muscle contractions via electrical stimulation.
This ability to interface a lab-grown mini human brain with a living spinal cord and muscles to control movement is an utterly groundbreaking achievement. The researchers suggest their integrated organoid system models the key features of motor neurons that degenerate in devastating disorders like ALS and spinal muscular atrophy.
According to Muotri, “We are dealing with something that looks a lot like an embryonic brain…We are building the tools to study human neurological diseases.”
Motor neurons are specialized nerve cells in the brain and spinal cord that control our voluntary muscle movements. The progressive death of motor neurons occurs in several neurological conditions, robbing patients of mobility and independence.
ALS, for instance, is a ruthless disorder in which motor neurons degenerate, leading to paralysis and respiratory failure. Patients sadly succumb within 2 to 5 years of diagnosis, frequently from inability to breathe.
Likewise, spinal muscular atrophy stems from loss of motor neurons, resulting in declining muscle control and often early death.
The intricate biology underlying why motor neurons die in these disorders remains poorly understood, stymying treatment development. Because animals lack human complexity, an advanced human model is urgently needed to unravel disease mechanisms.
Muotri’s innovative organoid-spinal cord linkage empowers researchers to explore factors that orchestrate motor neuron development and death in a unique living human system. Leveraging stem cell biology and tissue engineering, the research team grew a cellular bridge between human and mouse neural tissues.
In the study, the organoid patches were observed projecting dense bundles of axons that infiltrated the mouse spinal cord and made synaptic connections with mouse motor neurons. Stimulating these neural extensions activated muscles in the mouse body in a strength-dependent manner, just as normal motor neuron activity does.
Moreover, the interface model could shed light on why motor neuron connections are disrupted in neurodegenerative diseases. Through examining a patient’s own organoid-spinal tissue, researchers may identify personalized mechanisms of disease. These insights could lead to targeted treatments that prevent motor neuron death and muscle paralysis.
While still at an early stage, Muotri’s organoid-spinal linkage represents a quantum leap for modeling neurological conditions. In the future, the system could accelerate screening and development of drugs to treat disorders of neuronal connectivity like ALS and spinal cord injury. However, another stem cell therapy – transplantation of live stem cells – may offer the most direct route to reversing motor neuron disease.
Stem Cell Medical Center deploys stem cell transplantation to reignite patients’ innate healing processes and regenerate damaged tissue in neurological disorders. Stem cells sourced from donated umbilical cord tissue offer key advantages of youth, potency, and immunological naivety that drive their reparative powers.
When expertly delivered into the body, stem cells home to sites of injury and disease where they orchestrate repair in multiple ways:
Dramatic recoveries have already been witnessed following stem cell treatment in patients with ALS, spinal cord injury, stroke, multiple sclerosis and other neurological conditions. Published evidence indicates stem cell therapy may help:
While lifelong neurological deficits cannot yet be fully reversed, stem cell therapy strives to maximally restore nerve, brain and muscle function possible for each patient. This can translate into renewed quality of life and hope.
Through the innate healing intelligence of stem cells, neurological patients are taking their first steps, greeting loved ones again with a smile, and reclaiming their dignity. The future of regenerative medicine for neurological disease is bright.
The stripping away of mobility, cognition and dignity that progressively occurs in illnesses like ALS, Parkinson’s disease and stroke is absolutely devastating. Patients and families understandably seek solutions that are safe yet go beyond marginally slowing disease when possible.
The scientific strides opening new curative possibilities for those suffering from neurological disorders are enormously heartening. Transplanting nature’s healing agents – stem cells – into the body to spur tissue regeneration and functional recovery represents the leading edge of that hope.
Stem Cell Medical Center integrates leading stem cell technologies with first-rate medical care, resort amenities, and a compassionate patient experience. Their expert team focuses on maximizing treatment potential for neurological patients while making their visit seamless and comfortable.
The Center continually tracks advances in neuroscience, like the latest organoid breakthrough, to inform and refine their treatment protocols. Their patient-centered approach includes:
While a single miracle cure for neurological disease remains on the horizon, today’s integrated therapies aim to reverse course and make the irreversible possible again.
Contact us and schedule a consultation to see if you may benefit from regenerative treatments. Stem cell therapy could alleviate your pain and help you regain mobility.